COMMUNIQUÉS West-GlobeNewswire

TiGenix ouvre à Cambridge (Massachusetts) son siège central aux États-Unis
29/06/2017
COMMUNIQUÉ DE PRESSE TiGenix ouvre à Cambridge (Massachusetts) son siège central aux États-Unis La décision suit l'OPV de NASDAQ en 2016 et le lancement de l'essai clinique global de phase III pour Cx601 Les opérations [...]
Bio-on presents "The Matter". Bioplastic technology now open source for researchers around the world
29/06/2017
Bio-on presents "The Matter". Bioplastic technology now open source for researchers around the world Bio-on will make its natural and 100% biodegradable bioplastic, Minerv PHAs, available free of charge to researchers, [...]
Bio-on présente «The Matter». La technologie du bioplastique est désormais « Open source » au service des chercheurs du monde entier.
29/06/2017
Bio-on présente « The Matter ». La technologie du bioplastique est désormais « Open source » au service des chercheurs du monde entier. Bio-on mettra gratuitement le bioplastique naturel et entièrement (100%) [...]
Novartis receives EU approval for first-line use of Zykadia® in ALK-positive advanced non-small cell lung cancer (NSCLC)
29/06/2017
In ALK-positive advanced NSCLC patients, Zykadia demonstrated superior median progression-free survival (PFS) compared to SOC chemotherapy with maintenance[1] Zykadia benefit was also seen in patients with brain [...]
Minerva Neurosciences Announces Pricing of Public Offering of Common Stock
29/06/2017
WALTHAM, Mass., June 28, 2017 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company, today announced the pricing of an underwritten public offering of 5,000,000 shares [...]
Vectura Group plc: New development and licence agreement for a US inhaled generic (VR2081)
28/06/2017
Vectura Group plc New development and licence agreement for a US inhaled generic (VR2081) Chippenham, UK - 28 June 2017: Vectura Group plc (LSE: VEC) ("Vectura", "the Group"), an industry-leading device and formulation [...]
Innocoll Announces Scheme Meeting and Extraordinary General Meeting Voting Results
28/06/2017
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION FOR IMMEDIATE [...]
AC IMMUNE ANNOUNCES RESULTS OF ANNUAL GENERAL MEETING
28/06/2017
Lausanne, Switzerland, June 28, 2017 - AC Immune SA (NASDAQ: ACIU), a Swiss-based, clinical stage biopharmaceutical company focused on neurodegenerative diseases, today announced that the shareholders of the Company [...]
Arix Bioscience leads $45 million Series B financing round into LogicBio Therapeutics
28/06/2017
Arix Bioscience leads $45 million Series B financing round into LogicBio Therapeutics Funding to advance gene therapies targeting orphan paediatric disorders through clinical trials LONDON, 28 June, 2017: Arix [...]
Medtronic SureTune(TM)3 Earns CE Mark for Deep Brain Stimulation Therapy
28/06/2017
Data Presented at the 17th Quadrennial Meeting of the World Society for Stereotactic and Functional Neurosurgery in Berlin DUBLIN and BERLIN - June 28, 2017 - Medtronic plc (NYSE: MDT) today announced it has received CE [...]
Summit Therapeutics plc : Grant of Share Options
28/06/2017
Summit Therapeutics plc ("Summit" or the "Company") GRANT OF SHARE OPTIONS Oxford, UK, 28 June 2017 - Summit Therapeutics plc (AIM: SUMM, NASDAQ: SMMT), the drug discovery and development company advancing therapies for [...]
Summit Therapeutics plc : Exercise of Share Options
28/06/2017
Summit Therapeutics plc ("Summit" or the "Company") EXERCISE OF SHARE OPTIONS Oxford, UK, 28 June 2017 - Summit Therapeutics plc (AIM: SUMM, NASDAQ: SMMT), the drug discovery and development company advancing therapies [...]
MITHRA SIGNS EXCLUSIVE LICENSE AND SUPPLY AGREEMENT WITH FUJI PHARMA FOR DONESTA® IN JAPAN AND ASEAN
28/06/2017
Mithra signs EXclusive license and supply agreement with FUJI Pharma for donesta® in japan and asean Fuji Pharma obtains rights to commercialize Donesta®, Mithra's Hormone Therapy (HT) product candidate based on [...]
MDxHealth Presents Three SelectMDx Studies at 5th Global Congress on Prostate Cancer
28/06/2017
NEWS RELEASE / REGULATED INFORMATION / INSIDE INFORMATION IRVINE, CA, and HERSTAL, BELGIUM - 07:00 CEST, June 28 2017 - MDxHealth SA (Euronext: MDXH.BR) today announced its activities at the fifth Global Congress on [...]
MDxHealth présente trois études SelectMDx lors du 5e congrès mondial sur le cancer de la prostate
28/06/2017
COMMUNIQUE DE PRESSE / INFORMATION REGLEMENTAIRE / INFORMATION PRIVILEGIEE IRVINE, CA, et HERSTAL, BELGIQUE - 07:00 AM CEST - Le 28 juin 2017 - MDxHealth SA (Euronext: MDXH.BR) a annoncé aujourd'hui ses activités lors [...]
Minerva Neurosciences, Inc. to Offer Common Shares
27/06/2017
WALTHAM, Mass., June 27, 2017 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company, today announced its intention to offer and sell 5,000,000 shares of its common [...]
La demande relative aux interventions de chirurgie esthétique dans le monde continue de s'envoler : les États Unis, le Brésil, le Japon, l'Italie et le Mexique classés comme les cinq principaux pays
27/06/2017
NEW YORK, le 27 juin 2017 (GLOBE NEWSWIRE) - L'International Society of Aesthetic Plastic Surgery (ISAPS) a publié aujourd'hui les résultats de son enquête annuelle mondiale (Global Aesthetic Survey) sur les [...]
Nestlé outlines future value creation model including strategic growth priorities and supporting capital structure
27/06/2017
This press release is also available in Français (pdf) and Deutsch (pdf) ....................................... Vevey, 27 June 2017 Nestlé outlines future value creation model including strategic growth priorities and [...]
Mithra Pharmaceuticals: INFORMATION ON THE TOTAL NUMBER OF VOTING RIGHTS (DENOMINATOR)
27/06/2017
Information on the total number of voting rights (denominator) Liège, Belgium , 27 June 2017 [ 5:45 pm CET ] - Regulated information - In accordance with article 15 of the Act of 2 May 2007 on the disclosure of large [...]

Pages